Effects of Coenzyme Q10 on Statin‐Induced Myopathy: An Updated Meta‐Analysis of Randomized Controlled Trials

Влияние коэнзима Q10 на миопатию, индуцированную статинами: обновлённый метаанализ рандомизированных контролируемых исследований
Hua Qu, Ming Hao Guo, Hua Chai, Wen‐ting Wang, Zhu‐ye Gao, Dazhuo Shi
2018-09-25

Coenzyme Q10 supplementationmeta-analysisrandomized controlled trialsstatin-associated muscle symptomsstatin-induced myopathy
Background Previous studies have demonstrated a possible association between the induction of coenzyme Q10 (CoQ10) after statin treatment and statin-induced myopathy. However, whether CoQ10 supplementation ameliorates statin-induced myopathy remains unclear. Methods and Results PubMed, EMBASE , and Cochrane Library were searched to identify randomized controlled trials investigating the effect of CoQ10 on statin-induced myopathy. We calculated the pooled weighted mean difference ( WMD ) using a fixed-effect model and a random-effect model to assess the effects of CoQ10 supplementation on statin-associated muscle symptoms and plasma creatine kinase. The methodological quality of the studies was determined, according to the Cochrane Handbook. Publication bias was evaluated by a funnel plot, Egger regression test, and the Begg-Mazumdar correlation test. Twelve randomized controlled trials with a total of 575 patients were enrolled; of them, 294 patients were in the CoQ10 supplementation group and 281 were in the placebo group. Compared with placebo, CoQ10 supplementation ameliorated statin-associated muscle symptoms, such as muscle pain ( WMD , -1.60; 95% confidence interval [ CI ], -1.75 to -1.44; P<0.001), muscle weakness ( WMD , -2.28; 95% CI , -2.79 to -1.77; P=0.006), muscle cramp ( WMD , -1.78; 95% CI , -2.31 to -1.24; P<0.001), and muscle tiredness ( WMD , -1.75; 95% CI , -2.31 to -1.19; P<0.001), whereas no reduction in the plasma creatine kinase level was observed after CoQ10 supplementation ( WMD , 0.09; 95% CI , -0.06 to 0.24; P=0.23). Conclusions CoQ10 supplementation ameliorated statin-associated muscle symptoms, implying that CoQ10 supplementation may be a complementary approach to manage statin-induced myopathy.
1
An updated meta-analysis included 12 randomized controlled trials involving 575 patients evaluating CoQ10 for statin-induced myopathy.
2
CoQ10 supplementation did not significantly reduce plasma creatine kinase levels (WMD, 0.09; 95% CI, -0.06 to 0.24; P=0.23).
3
Compared with placebo, CoQ10 supplementation significantly reduced statin-associated muscle pain, weakness, cramping, and tiredness.
4
The findings suggest CoQ10 may serve as a complementary approach for managing statin-induced myopathy, particularly its muscle symptoms.
5
The pooled effects favored CoQ10 for muscle pain (WMD, -1.60), weakness (WMD, -2.28), cramping (WMD, -1.78), and tiredness (WMD, -1.75).

statin-induced myopathy in patients receiving statin treatment

the effects of CoQ10 supplementation on statin-associated muscle symptoms and plasma creatine kinase levels

Publication Details
Publication Date
2018-09-25
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Hua Qu
Ming Hao Guo
Hua Chai
Wen‐ting Wang
Zhu‐ye Gao
Dazhuo Shi
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%